- Home
- » Tags
- » Rilpivirine
Top View
- Antiviral Drugs in the Treatment of Aids: What Is in the Pipeline ?
- Rilpivirine: Pediatric Medication
- Product Monograph for Juluca
- Odefsey Gilead Sciences Pty Ltd PM-2015-02479-1-2 Final 12 October 2017
- Dolutegravir-Rilpivirine for Treating HIV-1 in Adults
- Odefsey, INN-Emtricitabine / Rilpivirine / Tenofovir Alafenamide
- Ethnicity-Specific Drug Safety Data in European Medicines Agency
- Cabotegravir
- GLASS Methodology for Surveillance of National Antimicrobial Consumption
- Rilpivirine in the Treatment of HIV Infection: Evidence from the ECHO and THRIVE Studies
- Drug Interactions with Antiretroviral Medications
- Edurant, INN-Rilpivirine
- Vocabria, INN-Cabotegravir
- Nevirapine (Viramune)
- Rilpivirine (Edurant) FACT SHEET Summary Published Rilpivirine Is a Type of Anti-HIV Drug Called a Non-Nuke, Or 2014 NNRTI
- Nucleoside Reverse Transcriptase Inhibitors In
- ODEFSEY (Emtricitabine, Rilpivirine, and Tenofovir
- Rilpivirine Nevirapine, Efavirenz, Etravirine, and Infectious Molecular Clones Resistant to Panel of Prototypical Recombinant
- Parenteral Inhibitors of HIV Entry in Current Development The
- Full Article In
- Efficacy and Safety of Abacavir/Lamivudine Plus Rilpivirine As a First-Line Regimen in Treatment-Naïve HIV-1 Infected Adults
- Application for Inclusion of Fixed Dose, Three-Drug Combination Odefsey
- Cabotegravir Gsk1265744 (744)
- Review Novel Compounds for the Treatment of HIV Type-1 Infection
- 2019 Update of the Drug Resistance Mutations in HIV-1
- Advances in Long-Acting Agents for the Treatment of HIV Infection
- Bioequivalence of the Emtricitabine/Rilpivirine/Tenofovir
- Rilpivirine (Edurant®): RMP Summary
- JULUCA™ (Dolutegravir Sodium-Rilpivirine Hydrochloride) Oral Tablet
- Rilpivirine/ Emtricitabine/ Tenofovir Alafenamide
- EDURANT with Drugs That May These Highlights Do Not Include All the Information Needed to Use Reduce the Exposure of Rilpivirine
- COMPLERA Safely and Effectively
- Long-Acting Intramuscular Cabotegravir and Rilpivirine
- Darunavir Stands up As Preferred HIV Protease Inhibitor
- EDURANT® (Rilpivirine)
- Edurant, INN-Rilpivirine Hydrochloride
- Effect of Food on Rilpivirine/Emtricitabine/ Tenofovir
- Information on Crushing and Liquid Drug Formulations
- Eviplera, INN-Emtricitabine / Rilpivirine / Tenofovir Disoproxil
- Original Article Efficacy and Safety of a Switch to Rilpivirine-Based Regimens in Treatment-Experienced HIV-1-Infected Patients: a Cohort Study
- CABENUVA-VOCABRIA Product Monograph
- New Dual Combination of Dolutegravir-Rilpivirine For
- Page: Treatment-Drugs
- WO 2012/151165 Al 8 November 2012 (08.11.2012) P O P C T
- Rilpivirine Pharmacokinetics With/Without Darunavir/R in Adolescents and Young Adults
- Rilpivirine PK Fact Sheet Revised February 2017 Page 1 of 2 for Personal Use Only
- Non-Nucleoside Reverse Transcriptase Inhibitors In
- ARV-ARV Drug Combinations to Be Avoided (DUR POS Edits)
- Small Molecules of Natural Origin As Potential Anti-HIV Agents: a Computational Approach
- Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
- ESAC-Net Reporting Protocol 2018.Docx Introduction
- CONCLUSION and RELEVANCE the Analysis of Prescriptions in the Period 2016-2019 Showed a Decrease in TDF-Based Therapies in Favor of TAF-Based Prescribing Regimens